NEW YORK, March 06, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Babcock & Wilcox Enterprises, Inc. ("Babcock & Wilcox") (NYSE:BW) between July 1, 2015 and February 28, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of North Carolina. To get more information go to:
http://www.zlk.com/pslra-sa/babcock-wilcox-enterprises-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) although the Company disclosed issues with a single project in its Renewable business segment, it failed to disclose that similar problems were significantly impacting other projects in the same segment; and (2) the Company assured investors that the problems were "a single project issue."
On February 28, 2017, Babcock & Wilcox announced its fourth quarter and full year 2016 financial results, announcing it lost $71.6 million or $1.47 per share in the fourth quarter. The Company also announced it took charges in the fourth quarter of 2016 resulting from its Renewable business, which reduced margins, and increased its contingencies for several of its Renewable projects. On this news, shares of Babcock & Wilcox fell approximately 37% to close at $10.33 per share on March 1, 2017.
If you suffered a loss in Babcock & Wilcox you have until May 2, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



